InfuSystem Holdings, Inc.

Equities

INFU

US45685K1025

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
8.12 USD +6.70% Intraday chart for InfuSystem Holdings, Inc. -0.98% -22.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc CI
Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024
Infusystem Announces Operational And Financial Results For Q4 And FY 2023 RE
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q4 Revenue $31.8M MT
InfuSystem Holdings, Inc. Provides Earnings Guidance for the Full Year 2024 CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
InfuSystem Holdings, Inc. Announces Resignation of R. Rimmy Malhotra as Member of the Board CI
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021. CI
Transcript : InfuSystem Holdings, Inc., Q3 2023 Earnings Call, Nov 07, 2023
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q3 Revenue $31.9M MT
InfuSystem Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
InfuSystem Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 CI
InfuSystem Holdings, Inc. Raises Earnings Guidance for the Full Year 2023 CI
InfuSystem, Dignitana Sign Sales, Marketing Partnership to Offer DigniCap Scalp Cooling System in the US MT
Dignitana Signs Sales & Marketing Deal With US-based InfuSystem; Shares Drop MT
Dignitana AB Announces Sales and Marketing Partnership with InfuSystem Holdings, Inc. to Provide Scalp Cooling Systems in the United States CI
Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021. CI
Transcript : InfuSystem Holdings, Inc., Q2 2023 Earnings Call, Aug 03, 2023
Earnings Flash (INFU) INFUSYSTEM HOLDINGS Posts Q2 Revenue $31.7M MT
InfuSystem Holdings, Inc. Revises Earnings Guidance for the Year 2023 CI
InfuSystem Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell 3000E Growth Index CI
InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell Small Cap Completeness Index CI
InfuSystem Holdings, Inc.(NYSEAM:INFU) added to Russell Small Cap Comp Growth Index CI
Chart InfuSystem Holdings, Inc.
More charts
InfuSystem Holdings, Inc. is a health care service provider that facilitates outpatient care for durable medical equipment manufacturers and health care providers. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.12 USD
Average target price
14.75 USD
Spread / Average Target
+81.65%
Consensus
  1. Stock Market
  2. Equities
  3. INFU Stock
  4. News InfuSystem Holdings, Inc.
  5. Earnings Flash (INFU) INFUSYSTEM HOLDINGS Reports Q4 Revenue $31.8M